Blood-Stage Parasitaemia and Age Determine Plasmodium falciparum
                and P. vivax Gametocytaemia in Papua New Guinea by Koepfli, Cristian et al.
RESEARCH ARTICLE
Blood-Stage Parasitaemia and Age
Determine Plasmodium falciparum and P.
vivax Gametocytaemia in Papua New Guinea
Cristian Koepfli1,2☯, Leanne J. Robinson1,2,3☯, Patricia Rarau3, Mary Salib3,
Naomi Sambale3, Rahel Wampfler4,5, Inoni Betuela3, Wang Nuitragool6, Alyssa E. Barry1,2,
Peter Siba3, Ingrid Felger4,5, Ivo Mueller1,2,7*
1 Walter and Eliza Hall Institute, Population Health and Immunity Division, Parkville, Victoria, Australia,
2 University of Melbourne, Department of Medical Biology, Parkville, Victoria, Australia, 3 Papua New
Guinea Institute of Medical Research, Vector Borne Diseases Unit, Madang, Papua New Guinea, 4 Swiss
Tropical and Public Health Institute, Medical Parasitology and Infection Biology, Basel, Switzerland,
5 University of Basel, Basel, Switzerland, 6 Faculty of Tropical Medicine, Mahidol University, Bangkok,
Thailand, 7 ISGlobal, Barcelona Centre for International Health Research, Barcelona, Spain
☯ These authors contributed equally to this work.
* ivomueller@fastmail.fm
Abstract
A better understanding of human-to-mosquito transmission is crucial to control malaria. In
order to assess factors associated with gametocyte carriage, 2083 samples were collected in
a cross-sectional survey in Papua NewGuinea. Plasmodium species were detected by light
microscopy and qPCR and gametocytes by detection of pfs25 and pvs25mRNA transcripts
by reverse-transcriptase PCR (qRT-PCR). The parasite prevalence by PCR was 18.5% for
Plasmodium falciparumand 13.0% for P. vivax. 52.5% of all infections were submicroscopic.
Gametocytes were detected in 60% of P. falciparum-positive and 51% of P. vivax-positive
samples. Each 10-fold increase in parasite density led to a 1.8-fold and 3.3-fold increase in
the odds of carrying P. falciparum and P. vivax gametocytes. Thus the proportion of gameto-
cyte positive and gametocyte densities was highest in young children carrying high asexual
parasite densities and in symptomatic individuals. Dilution series of gametocytes allowed ab-
solute quantification of gametocyte densities by qRT-PCR and showed that pvs25expression
is 10-20 fold lower than pfs25expression. Between 2006 and 2010 parasite prevalence in the
study site has decreased by half. 90% of the remaining infections were asymptomatic and
likely constitute an important reservoir of transmission. However, mean gametocyte densities
were low (approx. 1-2 gametocyte/μL) and it remains to be determined to what extent low-
density gametocyte positive individuals are infective to mosquitos.
Introduction
Understanding Plasmodium spp. transmission from the human host to the mosquito vector is a
key priority in the attempt to control and eventually eliminate malaria. While most malaria
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parasites in the human host replicate asexually, a small proportion of them enter the sexual
pathway and form morphologically and functionally different gametocytes. Malaria transmis-
sion depends on mosquitos taking up both male and female gametocytes and transmitting
their progeny to the next human host.
The biology of Plasmodium falciparum and P. vivax gametocytes differ [1]. P. falciparum ga-
metocytes are sequestered during development and only mature gametocytes circulate. They
appear 7–15 days after the initial wave of asexual stages in the blood stream [2], thus usually
after the first febrile symptoms. In contrast P. vivax gametocytes appear in the blood stream
shortly after the first appearance of asexual blood stage parasites and before the onset of clinical
disease [3]. In addition individual P. falciparum gametocytes circulate for 3–4 weeks [4,5],
while P. vivax gametocytes only survive for a few days [6].
By light microscopy (LM), the proportion P. falciparum gametocyte positive (i.e. the pro-
portion of gametocyte carriers among all P. falciparum positive individuals) in symptomatic in-
dividuals with high asexual parasite densities (often>5000 parasites/μL) ranged from 2.4 to
17% in Thailand and West Africa [7–11]. When gametocyte carriage was assessed by LM in
both P. falciparum and P. vivax clinical cases, the proportion P. vivax gametocyte positive was
6–8 times higher than that of P. falciparum [8,12,13] reaching rates of 57–92% in different
Asian countries [8,14,15]. The prevalence of gametocytes in the general population, in particu-
lar in asymptomatic individuals, has been studied in only few malaria-endemic regions [16–
18]. A study in Madang Province, Papua New Guinea reported that 9.8% of P. falciparum-
compared to 36.3% of P. vivax-infected individuals carried gametocytes [19]. The proportion
gametocyte positive was highest in children and decreased rapidly with age.
As the amount of blood examined is limited and only a small fraction of all parasites are ga-
metocytes, microscopic detection of gametocytes has limited sensitivity of around 10–20 game-
tocytes/μL blood. Molecular assays, based on amplification of gametocyte specific RNA
transcripts, have revealed 2–8 times higher gametocyte prevalence than light microscopy [20–
24]. Using molecular assays, proportions of P. falciparum gametocyte carriers amongst P. fal-
ciparum positive individuals ranged from 12% in asymptomatic carriers [25] to 15% in a cross-
sectional survey [20] and 89–91% in clinical infections [21,24]. The proportion P. vivax game-
tocyte positive reached 95% both in febrile patients [24] and in cross-sectional surveys [26].
In mosquito feeding experiments it has been repeatedly shown that individuals that carry
gametocytes at submicroscopic levels are infective, both for P. falciparum [23,27,28] and P.
vivax [29,30]. While individuals who were gametocyte positive by LM were considerably more
infective than individuals with only asexual parasites [13,28,30,31], the latter likely contribute
substantially to transmission due to the large proportion of asymptomatic individuals carrying
low-moderate density infections, [23].
Little is known about the factors associated with gametocyte prevalence and density, such as
acquired immunity, clinical disease and age. To identify carriers of P. falciparum and P. vivax
gametocytes, we conducted a cross-sectional survey in Papua New Guinea. Blood-stage para-
sites and gametocytes were detected by highly sensitive quantitative PCR (qPCR) and reverse-
transcriptase qPCR (qRT-PCR) assays.
Material and Methods
Ethical statement
Written informed consent was obtained from all study participants or their parents or legal
guardians. The study was approved by PNG IMR IRB, the PNGMedical Research Advisory
Committee (MRAC 05.20 & 12.06) and the WEHI Human Research Ethics Committee.
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Sample collection
The study was conducted in May-June 2010 in 3 communities (Malala, Mugil and Utu) in
Madang Province PNG, approximately two years after long-lasting insecticide treated bed nets
(LLINs) were distributed to all households [32]. The region receives over 3,000 mm of rainfall
annually with a short dry season (June to October) and has hyper-endemic malaria transmis-
sion that is moderately seasonal (lower in the drier season).
From each participant demographic data was recorded, history of febrile illness and data on
bed net use. Axillary temperature was measured, 250–300μL of capillary blood collected into a
K+EDTA microtainers, thick/thin films were prepared and haemoglobin measured (Hemo-
cue). For statistical purposes individuals were classified as non-anaemic (Hb11g/dL), having
mild anaemia (Hb 8–10.9 g/dL), and having moderate-to-severe anaemia (Hb<8g/dL). In the
case of reported febrile illness or axillary temperature>37.5°C, a rapid malaria diagnostic test
(ICT Combo) was performed and those positive by RDT treated with Artemether-Lumefan-
trine (Coartem). For RNA preservation, 50μL of whole blood was transferred to a tube contain-
ing 250μL of RNAProtect (Qiagen) within 8 hours of collection and stored at -80°C until RNA
extraction. In previous studies, transfer of blood to RNAprotect within 4 hours after collection
was shown to maintain high-quality RNA and thus optimal sensitivity of gametocyte detection
[33]. In addition, no effect on RNA quality was observed when samples were stored at ambient
temperature for up to 24 hours prior to long-term storage at -80° (A. Waltmann, S. Karl et al,
manuscript in preparation). The remaining blood was centrifuged, the plasma removed and
stored at -80°C, and the red cell pellet stored at -20°C until DNA extraction.
Parasite detection
Blood slides were examined (minimum of 200 high-powered fields) independently by two ex-
perienced microscopists with discrepancies adjudicated by a third microscopist. Parasite densi-
ties were calculated from the number of parasites per 200 or 500 white blood cells (WBCs)
(depending on parasitaemia) and an assumed total peripheral WBC count of 8,000/μL [34]
with the final density taken as the arithmetic mean of the two values.
DNA was extracted from the equivalent of 200μL blood using the Favorgen 96-well Geno-
mic DNA Extraction Kit and eluted in 200μL buffer. A genus-specific quantitative PCR
(qPCR) that amplifies a conserved region of the 18S rRNA gene was run on all samples [33].
For P. falciparum, P. vivax, P.malariae and P. ovale species typing, species-specific qPCRs
were run as described [35]. The 18S rRNA gene amplified by qPCR is present in 3 copies per
genome. Copy numbers were quantified based on serial dilutions of plasmid controls run in
parallel. The detection limit (defined as>50% of plasmid standards positive) was 1–2 copies
per μL for all qPCRs.
Gametocyte detection and quantification
The number of P. falciparum and P. vivax gametocytes were recorded separately from asexual
stages during microscopic examination of all blood slides.
For gametocyte detection by qRT-PCR, RNA was extracted from all P. falciparum or P.
vivax qPCR-positive samples using the Qiagen RNeasy plus 96 kit, including Genomic DNA
removal by gDNA eliminator columns and DNase (Qiagen). Absence of gDNA in all samples
was confirmed by the same genus-specific, DNA-based qPCR used for parasite detection. In a
separate PCR reaction, presence of parasite RNA after extraction was verified by quantitative
reverse-transcriptase PCR (qRT-PCR) detecting 18S-RNA with the same primers and probe as
the genus-specific qPCRs.
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P. falciparum and P. vivax gametocytes were detected by qRT-PCR of the highly expressed
gametocyte markers pfs25 and pvs25 as described [33]. The number of pfs25 transcripts per P.
falciparum gametocyte had previously been calculated based on comparisons of microscopy
counts and qRT-PCR results of different dilutions of cultured P. falciparum gametocytes. A
non-linear relation was found and it was estimated that the qRT-PCR detects 50–180 pfs25
transcripts per circulating P. falciparum gametocyte, depending on gametocyte density [33].
Two independent P. vivax gametocyte trend-lines were generated from enriched gameto-
cytes from P. vivax patients from Thailand (2 isolates, 21–24% gametocytes, 64–70% of all ga-
metocytes female) and Brazil (3 isolates, 23–42% gametocytes, 24–71% of all gametocytes
female). Leukocyte-depleted blood was passed through a MidiMacs column (Miltenyi Biotec),
gametocytes and other stages (mostly trophozoites) were eluted and resuspended in RPMI me-
dium. Two samples were stored in TRIzol, and a 10-fold serial dilution (5 steps) was made
after RNA extraction. Three samples were diluted 10-fold (3 steps) before adding RNAprotect
and storing. The final RNA concentration corresponded to densities of 104 to 1 gametocytes/
μL blood. Pvs25 transcripts/μL were quantified by qRT-PCR; plasmid standards were run in
parallel for absolute quantification. Conversion factors for pvs25 transcript numbers into num-
bers of gametocytes were calculated with a random-effect model from log10-transformed
quantities of the gametocyte trend-lines. Samples were set as random effect.
Data analysis
Malaria episodes were defined as febrile illness (axillary temperature>37.5°C measured at
time of sampling and/or fever reported from previous 48 hours) in the presence of P. vivax or
P. falciparum asexual parasites by LM (any density). Parasite and gametocyte densities were
log transformed and geometric means per μL whole blood calculated wherever densities are re-
ported. Multivariate analysis of factors associated with gametocyte carriage was conducted
using logistic regression and associations with gametocyte density investigated by linear regres-
sion. All analyses were performed using Stata 12 or R version 2.14.0.
Results
A total of 2083 individuals with age distribution representative for the population were sur-
veyed; demographic and clinical characteristics are summarized in Table 1.
Overall, the prevalence rate (PR) by light microscopy was 7.4% P. falciparum, 7.0% P. vivax,
0.29% P.malariae, 0% P. ovale and 0.9% mixed P. falciparum/P. vivax. The overall prevalence
of clinical malaria was 1.6% (n = 34); 88.1% of all LM-positive infections were asymptomatic
(Table 1).
52.9% of P. falciparum-positive samples had only asexual stages, 24.5% only gametocytes
and 22.6% both. Of P. vivax-positive samples 70.5% had asexual stages only, 2.1% gametocytes
only and 27.4% both. By LM P. falciparum gametocytes were thus detected in 73 (3.5%) indi-
viduals and P. vivax gametocytes in 43 (2.1%) individuals. Geometric mean asexual and sexual
parasite densities by LM were 808.0 (CI95[579.3–1127.0]) and 158.3 (CI95[117.4–213.3]) P. fal-
ciparum parasites/μL and 117.6 (CI95[97.3–142.1]) and 34.9 (CI95[26.9–45.3]) P. vivax para-
sites/μL. For both species, overall prevalence (Fig 1A, P<0.001) and the proportion gametocyte
positive (Fig 1B, Pf: P = 0.010, Pv: P = 0.002) differed significantly between age groups.
Parasite prevalence by PCR
By qPCR, 385 out of 2083 samples (18.5%) were positive for P. falciparum and 270 (13.0%) for
P. vivax. Of these, 81 (3.9%) carried both species. P.malariae and P. ovale were rare (28 and 2
infections) and occurred mostly (17/30) in participants concurrently infected with P.
Plasmodium falciparum and P. vivaxGametocytaemia in Papua New Guinea
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falciparum and/or P. vivax. Of all individuals positive by PCR, 52.5% were negative by LM,
89.6% were asymptomatic and 5.6% met the definition of clinical malaria (fever and parasites
detected by LM). Prevalence for P. falciparum and P. vivax showed pronounced differences be-
tween age groups (Fig 1A, P<0.001) with P. falciparum peaking in individuals 12–20 years of
age and P. vivax peaking in children 6–9 years of age. P. falciparum prevalence was higher in
mild-moderately anaemic and febrile individuals, whereas P. vivax was less common in indi-
viduals with recent malaria episodes (Tables 2 and 3).
Geometric mean parasite densities by qPCR were very low with 126.8 (CI95 [91.1–176.5])
copies per μL/blood for P. falciparum and 23.8 (CI95 [19.5–29.1]) copies/μL for P. vivax. As-
suming that all 3 copies of the marker gene were amplified, this corresponds to 42 P. falcipa-
rum and 8 P. vivax genomes per μL. Densities of P. falciparum and P. vivax were 14- and
10-fold lower in adults as compared to children<3 years (Fig 1C), and P. vivax densities
dropped more rapidly with age than P. falciparum densities (Fig 1C). In samples that were pos-
itive by both qPCR and LM, densities were more highly correlated for P. falciparum (rS = 0.81,
n = 144) than P. vivax (rS = 0.39, n = 139, S1 Fig).
Table 1. Demographic, clinical and parasitological characteristics of study participants.
n %
2083 100
Area Malala 936 44.9
Mugil 799 38.4
Utu 348 16.7
Age group (n = 1967) 0–3 291 14.0
>3–6 228 10.9
>6–9 224 10.6
>9–12 175 8.5
>12–20 198 9.5
>20 851 40.9
Bednet use (n = 2065) Yes 1594 76.5
Malaria last 2 weeks (n = 2973) Yes 166 8.0
Anti-malarials in last 2 weeks (n = 2078) Yes 61 2.9
Anaemia (n = 1816) No 763 36.6
Mild 942 45.2
Moderate 111 5.3
Current or recent febrile illness (n = 2083) Yes 199 9.5
Clinical Malaria P. falciparum 21 1.0
P. vivax 9 0.4
Pf/Pv mixed 5 0.2
Plasmodium spp. infection by LM P. falciparum 155 7.4
asexuals only 82
gametocytes only 38
both 35
P. vivax 146 7.0
asexuals only 103
gametocytes only 3
both 40
P. malariae 6 0.3
P. ovale 0 0
Pf/Pv mixed 10 0.9
doi:10.1371/journal.pone.0126747.t001
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Gametocyte prevalence by qRT-PCR
By qRT-PCR, 233/385 (60.5%) of P. falciparum positive and 132/270 (48.9%) of P. vivax posi-
tive individuals carried detectable gametocytes, resulting in a population gametocyte preva-
lence of 11.2% and 6.3%.
Fig 1. Age trends in P. falciparum and P. vivax blood-stage and gametocyte prevalence and density
Error bars represent CI95.
doi:10.1371/journal.pone.0126747.g001
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Table 2. Multivariate predictors of P. falciparum parasite prevalence and proportion of gametocyte positive.
Parasite prevalence (n = 1,714) Proportion gametocyte positive (n = 349)
% aOR 95% CI P-value % aOR 95% CI P-value
Gene copies/μL (log)1 1.85 [1.50, 2.28] <0.001
Mixed Pf/Pv (by pcr) No 63.8 1
Yes 48.2 0.40 [0.23, 0.71] 0.002
Age group 0–3 9.6 1 <0.001 64.3
>3–6 21.1 2.34 [1.38, 3.97] 72.9
>6–9 26.3 3.40 [2.04, 5.68] 78.0
>9–12 28.0 3.65 [2.12, 6.29] 59.2
>12–20 30.8 4.87 [2.88, 8.24] 59.0
>20 14.3 1.78 [1.13, 2.81] 46.7
Malaria last 2 weeks No 18.1 57.7 1
Yes 22.3 83.8 3.78 [1.42, 10.1] 0.008
Febrile No 17.8 1 0.001 58.0
Yes 24.6 1.87 [1.27, 2.75] 77.6
Anaemia No 14.7 1 <0.001 49.1 1 0.019
Mild 23.0 1.78 [1.36, 2.34] 66.1 1.63 [0.99, 2.70]
Moderate 20.7 1.70 [1.01, 2.84] 52.2 0.46 [0.16, 1.33]
aOR = adjusted odds ratio (adjusted for multivariate analysis), CI = conﬁdence interval
1 Increase in the probability that gametocytes are detected in a P. falciparum positive sample, if the parasite density increases 10-fold
doi:10.1371/journal.pone.0126747.t002
Table 3. Multivariate predictors of P. vivax parasite prevalence and proportion gametocyte positive.
Parasite prevalence (n = 1,958) Proportion gametocyte positive (n = 224)
% aOR 95% CI P-value % aOR 95% CI P-value
Gene copies/μL (log)1 2.85 [1.74, 4.67] <0.001
Mixed Pf/Pv (by pcr) No 48.7
Yes 49.4
Age group 0–3 10.0 1 <0.001 72.4 1 0.011
>3–6 20.2 2.35 [1.41, 3.90] 71.7 1.10 [0.32, 3.75]
>6–9 26.3 3.30 [2.02, 5.40] 55.9 0.53 [0.17, 1.68]
>9–12 19.4 2.26 [1.31, 3.88] 38.2 0.36 [0.10, 1.33]
>12–20 12.1 1.26 [0.71, 2.25] 41.7 0.33 [0.08, 1.31]
>20 7.0 0.69 [0.43, 1.11] 31.7 0.20 [0.06, 0.67]
Malaria last 2 weeks No 13.5 0.029 49.2
Yes 6.0 0.48 [0.25, 0.93] 40.0
Febrile No 13.2 48.8
Yes 11.1 50.0
Anaemia No 11.0 41.7 1 0.048
Mild 15.5 47.3 0.66 [0.34, 1.30]
Moderate 9.0 90.0 8.56 [0.94, 77.7]
aOR = adjusted odds ratio (adjusted for multivariate analysis), CI = conﬁdence interval
1 Increase in the probability that gametocytes are detected in a P. vivax positive sample, if the parasite density increases 10-fold
doi:10.1371/journal.pone.0126747.t003
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For both species, the likelihood to detect gametocytes was considerably higher in samples
with high blood-stage parasitaemia (Fig 2). Each log increase in parasite genome copy density
was associated with a 1.77-fold increase (CI95[1.47–2.13], P<0.001) in the odds of carrying P.
falciparum and a 3.27-fold increase (CI95[2.16–4.95], P<0.001) in the odds of carrying P. vivax
gametocytes. As a result gametocytes were detected in nearly all LM-positive infections (Pf:
88.2%, Pv: 79.3%) but in a much lower proportion of submicroscopic infections (Pf: 44.0%, Pv:
16.1%, P<0.001). P. falciparum gametocyte densities were 6-fold higher in samples positive by
microscopy as compared to submicroscopic infections (2.45 [1.50–3.99] vs. 0.39 [0.28–0.56]
Fig 2. pvs25 transcript numbers versus light microscopically determined P. vivax gametocyte counts.Dilution series were made before storing
samples in RNAprotect (5 dilution steps) or after RNA extraction of samples stored in TRIzol (3 dilution steps). Dots represent means of technical triplicates
(TRIzol) or quintuplicates (RNAprotect) of dilutions except for the highest concentration (no replicates). Shaded grey shows the CI95 of the intercept of the
regression of compiled sample sets.
doi:10.1371/journal.pone.0126747.g002
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gametocytes/uL), while P. vivax gametocyte densities were similar in both groups (2.77 [2.07–
3.71] vs. 2.22 [1.37–3.61] gametocytes/uL). Co-infections with P. vivax resulted in a significant-
ly lower proportion P. falciparum gametocyte positive (48.1% vs. 63.8%, P = 0.010) but not
vice versa.
P. falciparum gametocyte prevalence and the proportion gametocyte positive peaked in chil-
dren 6–9 years of age (20.5% and 78.0%) and was lowest (6.7% and 46.7%) in adults (P = 0.001,
Fig 1, Table 2). P. vivax gametocyte prevalence among all study participants decreased from
14.6% in children 3–9 years to 2.2% in adults (P<0.001; Table 3) while the proportion P. vivax
gametocyte positive dropped from 71–72% in children below 6 years to 31.7% in adults.
The proportion gametocyte positive for both species was also associated with haemoglobin
levels, albeit in different ways. P. falciparum gametocytes were most commonly present in par-
ticipants with mild anaemia (Table 2, Hb 8.0–10.9g/dL, 66.0%, P = 0.008), whereas P. vivax ga-
metocytes were most common in participants with moderate-to-severe anaemia (Hb<8g/dL;
Table 3, 90.0%). Lastly, participants who reported a malaria episode in the last 2 weeks were
more likely to have P. falciparum gametocytes (83.8% vs. 57.7%, P = 0.002; Table 2). After ac-
counting for all other factors, blood-stage parasitaemia remains the most important predictor
of carriage of gametocytes (Tables 2 and 3).
All symptomatic P. falciparum and 11/13 P. vivax infections carried gametocytes. However,
when corrected for asexual densities clinical malaria itself was not significantly associated with
gametocyte carriage for either species. Blood-stage P. falciparum and P. vivax parasitaemia was
Fig 3. Relationship between parasite density and probability that a sample is gametocyte positive.
Left: Probability (with CI95) that a sample is gametocyte positive vs. parasite density, calculated using a
general additive model. Right: correlation between gametocyte density (measured as pfs25 or pvs25
transcripts/uL) and parasite density by qPCR.
doi:10.1371/journal.pone.0126747.g003
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570- and 5-fold higher in symptomatic than in asymptomatic individuals (Pf: 48212
CI95[14358–161888] vs. 84.0 CI95 [62.1–113.6] parasites/μL, Pv: 104.4 CI95[28.2–387.1] vs. 21.8
CI95[17.9–26.6] parasites/μL).
Quantification of gametocytes by qRT-PCR
pfs25 densities were converted to P. falciparum gametocyte densities based on published trend-
lines: gametocytes/μL = 10−1.6225tpfs25
0.8518, where tpfs25 is the number of pfs25 transcripts/μL
detected by qRT-PCR [33]. This corresponds to approximately 50–180 pfs25 transcripts per cul-
tured P. falciparum gametocyte. For pvs25 expression, storage in TRIzol or RNAprotect resulted
in very similar trend-lines (Fig 3). The conversion [with CI95] obtained from samples stored in
TRIzol was: gametocytes/μL = 10−0.5546[-0.8973;-0.2120]tpvs25
0.8576[0.8057;0.9095]. Conversion of sam-
ples stored in RNAprotect was: gametocytes/μl = 10−0.7283[-1.3802; -0.0765]tpvs25
0.8804[0.7041; 1.0567].
For all further analysis, data was pooled and the following conversion applied: gametocytes/
μL = 10−0.5171[-0.7452;-0.2890]tpvs25
0.8339[0.8033;0.8645]. Thus one gametocyte roughly corresponds to
4.17 [2.16–8.47] pvs25 transcripts, though this is not a linear, but a logarithmic relationship,
where higher gametocyte densities show a higher number of transcripts/gametocyte.
Among qRT-PCR positive participants, mean pfs25 density was 86.4 transcripts/μL
(CI95[58.7–127.1]), and mean pvs25 density was 13.6 transcripts/μL (CI95[10.0–18.4]). This
corresponds to 1.06 (CI95[0.77–1.48]) P. falciparum and 2.67 (CI95[2.07–3.45]) P. vivax game-
tocytes/μL. Gametocyte densities were significantly higher in participants with LM-detectable
gametocytaemia (Pf: 12.1 vs. 0.37/μL P<0.001; Pv: 6.5 vs. 1.75/μL, P<0.01). For samples with
1 gametocyte/μL by qRT-PCR, a strong correlation between densities by LM and qRT-PCR
was observed (Pf: r = 0.696, P<0.001, Pv: r = 0.574, P = 0.001, for log-transformed values).
P. vivax gametocyte densities were strongly correlated with P. vivax blood-stage parasitae-
mia by qPCR (r = 0.636, P<0.001, log-transformed values). A small but still highly significant
correlation was also found between P. falciparum gametocyte and genome copy numbers
(r = 0.259, P<0.001) (Fig 2).
The age-associated reduction in gametocyte densities was even faster than that for blood-
stage parasite densities (Fig 1D, P<0.001). P. falciparum and P. vivax gametocyte densities
dropped 2.7-fold and 5.3-fold between children 0–3 and 3–6 years of age. P. falciparum game-
tocyte densities were significantly higher in individuals who reported a recent malaria episode
Table 4. Determinants of P. falciparum and P. vivax gametocyte density.
P. falciparum P. vivax
GMD β 95% CI P-value GMD β 95% CI P-value
Gene copies/μL (log) 0.13 [0.02, 0.24] 0.022 0.57 [0.43, 0.72] <0.001
Age group 0–3 21.1 0 <0.001 10.5 0 0.026
>3–6 15.2 -0.46 [-1.14, 0.21] 2.8 -0.47 [-0.81, -0.13]
>6–9 2.8 -1.04 [-1.70, -0.39] 2.0 -0.23 [-0.57, 0.11]
>9–12 8.9 -1.06 [-1.77, -0.35] 1.8 -0.55 [-0.97, -0.13]
>12–20 5.0 -1.31 [-2.00, -0.63] 1.9 -0.45 [-0.90, -0.00]
>20 3.2 -1.39 [-2.05, -0.74] 1.9 -0.55 [-0.95, -0.16]
Malaria last 2 weeks Yes 28.3 0.94 [0.48, 1.40] <0.001 61.9 NS
No 4.3 2.5
Intercept 0.53 [-0.15, 1.20] -0.46 [-0.88, -0.04] 0.032
GMD = geometric mean density, β = regression coefﬁcient, CI = conﬁdence interval
doi:10.1371/journal.pone.0126747.t004
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(5.7 vs. 0.83 gametocytes/μL P<0.001). These factors remain significantly associated in multi-
variate analyses (Table 4).
Discussion
Mass-distribution of LLINs in 2008 resulted in ~70% coverage [32] and led to a substantial re-
duction in malaria transmission in the study area. Compared to 2006 the prevalence of P. fal-
ciparum and P. vivax infections dropped from 39% to 18% and from 32% to 13%, respectively
[36,37]. Considerably fewer mixed-species infections were detected as compared to previous
studies in PNG, where up to 32% of all individuals sampled were infected by several species
concurrently [38,39]. Nevertheless, transmission of P. falciparum and P. vivax on the north
coast of PNG remains high, clinical immunity is acquired rapidly and—as a consequence—the
vast majority of infections are asymptomatic (90%) and of low density (52% submicroscopic).
These infections are not targeted by the current control strategy of ACT-based case manage-
ment plus LLINs, and thus constitute a potentially important reservoir of transmission.
qRT-PCR detected gametocytes in 60% of P. falciparum and 51% of P. vivax positive indi-
viduals. The results corresponded very well with an earlier PNG study that used identical meth-
ods and found 59% of P. falciparum and 52% of P. vivax positive children aged 5–10 carrying
gametocytes [33]. Gametocyte carriage was low compared to other studies, where nearly all in-
fected individuals carried gametocytes [22–24,26] and contradicts earlier studies based on light
microscopy that reported that considerably higher proportions of P. vivax than P. falciparum
infections carried gametocytes [8,13]. However, most of these other studies were conducted on
symptomatic patients with relatively high parasitaemia (>5000 parasites/μL) [8,13,22,24,26].
In this cross-sectional study, blood-stage parasite density was the strongest predictor for ga-
metocyte carriage. Thus for both species gametocytes were detected in almost all symptomatic
and the vast majority of LM-positive infections.
Parasite densities decrease at an early age, because in areas of intense transmission many indi-
viduals are immune or semi-immune to malaria [38,39]. Thus, the proportion of gametocyte
positive individuals was highest in young children. As only a small fraction of all parasites were
gametocytes, the number of gametocyte carriers detected among individuals carrying low para-
site densities was heavily dependent on the sensitivity of the assays and the amount of blood as-
sessed. Both the pfs25 and pvs25 qRT-PCRs were able to detect as little as 1–2 transcripts/μL
blood. Using the same detection techniques for P. falciparum gametocytes from culture [33] and
serial dilutions of P. vivax gametocytes from clinical cases, around 10-times more pfs25 than
pvs25 transcripts/gametocyte were detected. Thus in field samples as little as a single P. falcipa-
rum gametocyte can be detected in 50μL blood, assuming it provides 1–2 pfs25 transcripts/μL ex-
tracted RNA. For P. vivax, however, a density of 10 gametocytes/50μL blood would be required
for an equal probability of detection. This explains why no gametocytes were detected in 84% of
all submicroscopic P. vivax infections, and where detected, their similar densities in microscopy
positive and submicroscopic infections. Likely gametocytes were present in some of the submi-
croscopic, gametocyte negative infections, yet at densities below the detection limit of qRT-PCR.
The sensitivity of an assay for detection of blood-stage parasites, and thus the number of
parasite positive individuals, can greatly influence the proportion of gametocyte carriers and
therefore can explain differences between studies. The qPCR used in this study has a detection
limit of one 18S rRNA gene copy/μL and detects even very low parasite densities typical for
asymptomatic individuals. The same samples were screened with a nested PCR for Pfmsp2 and
Pvmsp1F3 followed by gel electrophoresis [40,41]. This assay was less sensitive and yielded
lower parasite prevalence rates but higher proportions of gametocyte positive samples (Pf:
69.5%, Pv: 66.7%). In a different study, detection of parasites based on highly abundant RNA
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instead of DNA led to a pronounced increase in prevalence, but the proportion of gametocyte
positive samples dropped from 59 to 41% for P. falciparum and from 53 to 36% for P. vivax
[33]. In conclusion, the more sensitive the assay to detect blood-stage parasites, the more very
low-density infections are detected, and the lower the proportion of gametocyte positive sam-
ples among all positive samples.
In this cross-sectional survey 56% P. falciparum and 81% P. vivax carriers had<100 18S
rRNA gene copies/μL. The smaller proportion of P. vivax than P. falciparum gametocyte carri-
ers is thus a consequence of the lower expression level of pvs25 as compared to pfs25 and the
lower average densities of P. vivax infections.
As expected qRT-PCR estimates of gametocytaemia were much more closely linked to para-
site densities by qPCR for P. vivax than for P. falciparum. P. vivax gametocytes mature rapidly
[1] and follow levels of asexual parasitaemia [3]. Blood-stage parasitaemia is therefore a good
surrogate marker for P. vivax gametocytaemia. P. falciparum gametocytes develop for 7–10
days in the bone marrow [42] before stage V gametocytes start appearing in the blood stream
[1]. In P. falciparum, gametocytaemia is thus likely to be more related to the parasitaemia two
weeks earlier than to concurrent parasitaemia.
LM and qRT-PCR estimates of gametocyte density were much more closely correlated for P.
falciparum than P. vivax, possibly because the characteristic ‘banana-shaped’ P. falciparum game-
tocytes are more easily identifiable than P. vivax gametocytes, which resemble asexual parasites.
At lower densities there was no correlation between the two measures for either species. By LM a
maximum of 0.0625μL blood was counted making estimates of densities error-prone. Further-
more, Plasmodium spp. are probably not randomly distributed in blood, autoagglutination of asex-
ual parasites was reported for P. falciparum [43]. It is possible that gametocytes also cluster to
increase the chance that at least one male and one female gametocyte being taken up in a 2–5μL
mosquito blood meal [44]. At densities<1 gametocyte/μL, detection of gametocytes in such small
volumes of blood examined by LM becomes stochastic. Estimates of gametocytaemia by qRT-PCR
based on RNA extracted from 50μL blood are thus likely more accurate than those by LM.
The contribution of very low-density gametocyte carriers to transmission is not clear. Infec-
tiveness of individuals negative by microscopy has been repeatedly reported. P. falciparum in-
fections with sub-patent gametocytaemia in children from Burkina Faso [45] and Kenya [27]
infected 24.2% and 43.5% of Anopheles gambiae, mosquitoes, respectively. Similarly, the infec-
tivity of sub-microscopic P. vivax infections has been shown in studies from Thailand [46–48],
Sri Lanka [49], Peru [30] and PNG [19]. The qRT-PCR applied detects 1–5 gametocytes/50μL
blood. At such low gametocyte densities, a mosquito might not always take up at least one male
and one female gametocyte in its 3–5μL blood meal [44] and therefore not all qRT-PCR posi-
tive individuals might be infective. Further studies comparing gametocyte quantification by
qRT-PCR to infectivity in mosquito feeding assays are thus needed to accurately quantify the
contribution of these very low-density infections to malaria transmission.
Supporting Information
S1 Fig. Correlation between qPCR and LM estimates of P. falciparum and P. vivax parasite
densities. The Spearman correlation for P. falciparum was 0.81 and for P. vivax 0.39.
(PDF)
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